716 related articles for article (PubMed ID: 22715953)
21. Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and meta-analysis.
Tan CJ; Ng ZQ; Bhattacharyya R; Sultana R; Lee JH
Pediatr Blood Cancer; 2023 Mar; 70(3):e30122. PubMed ID: 36579732
[TBL] [Abstract][Full Text] [Related]
22. [Hemophagocytic lymphohistiocytosis and macrophage activation syndrome : A multidisciplinary challenge].
Ruffer N; Kosch R; Weisel K; Kötter I; Krusche M
Z Rheumatol; 2024 Jun; 83(5):376-386. PubMed ID: 38267764
[TBL] [Abstract][Full Text] [Related]
23. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
24. Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.
Denimal D; Ménégaut L; Rossi C; Duvillard L; Masson D
Biochem Med (Zagreb); 2016; 26(2):255-9. PubMed ID: 27346972
[TBL] [Abstract][Full Text] [Related]
25. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
Rajagopala S; Singh N
Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
[TBL] [Abstract][Full Text] [Related]
26. Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.
Nyvlt P; Schuster FS; Ihlow J; Heeren P; Spies C; Hiesgen J; Schenk T; von Brünneck AC; Westermann J; Brunkhorst FM; La Rosée P; Janka G; Lachmann C; Lachmann G
Eur J Haematol; 2024 Jun; 112(6):917-926. PubMed ID: 38368850
[TBL] [Abstract][Full Text] [Related]
27. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.
Imashuku S; Hibi S; Ohara T; Iwai A; Sako M; Kato M; Arakawa H; Sotomatsu M; Kataoka S; Asami K; Hasegawa D; Kosaka Y; Sano K; Igarashi N; Maruhashi K; Ichimi R; Kawasaki H; Maeda N; Tanizawa A; Arai K; Abe T; Hisakawa H; Miyashita H; Henter JI
Blood; 1999 Mar; 93(6):1869-74. PubMed ID: 10068659
[TBL] [Abstract][Full Text] [Related]
28. Management of the critically ill child with the sepsis/hemophagocytic lymphohistiocytosis/macrophage activation syndrome overlap syndrome.
Demirkol D; Carcillo J
J Pediatr Intensive Care; 2014 Dec; 3(4):243-254. PubMed ID: 31214471
[TBL] [Abstract][Full Text] [Related]
29. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
[TBL] [Abstract][Full Text] [Related]
30. Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists.
Carter-Febres M; Lozano-Chinga M; Thomsen W; Treemarcki EB; James KE; Fluchel M
J Pediatr; 2023 Apr; 255():65-71.e6. PubMed ID: 36328191
[TBL] [Abstract][Full Text] [Related]
31. Similar but not the same: Differential diagnosis of HLH and sepsis.
Machowicz R; Janka G; Wiktor-Jedrzejczak W
Crit Rev Oncol Hematol; 2017 Jun; 114():1-12. PubMed ID: 28477737
[TBL] [Abstract][Full Text] [Related]
32. Hemophagocytic Lymphohistiocytosis Associated to
Zhang Z; Liu J; Wang J; Wang Y
Front Immunol; 2021; 12():684805. PubMed ID: 34335586
[TBL] [Abstract][Full Text] [Related]
33. High elevated ferritin levels and the diagnosis of HLH/Sepsis/SIRS/MODS/MAS.
Castillo L
Pediatr Blood Cancer; 2008 Nov; 51(5):710; author reply 710-1. PubMed ID: 18615508
[No Abstract] [Full Text] [Related]
34. Differential Diagnosis of Hyperferritinemia in Critically Ill Patients.
Schuster FS; Nyvlt P; Heeren P; Spies C; Adam MF; Schenk T; Brunkhorst FM; Janka G; La Rosée P; Lachmann C; Lachmann G
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614993
[TBL] [Abstract][Full Text] [Related]
35. [Hemophagocytic lymphohistiocytosis in critically ill patients].
Eichenauer DA; Lachmann G; La Rosée P
Med Klin Intensivmed Notfmed; 2021 Mar; 116(2):129-134. PubMed ID: 33580314
[TBL] [Abstract][Full Text] [Related]
36. Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.
Komiya Y; Saito T; Mizoguchi F; Kohsaka H
Intern Med; 2017; 56(23):3237-3241. PubMed ID: 29199203
[TBL] [Abstract][Full Text] [Related]
37. Extreme hyperferritinemia: etiological spectrum and impact on prognosis.
Belfeki N; Strazzulla A; Picque M; Diamantis S
Reumatismo; 2020 Jan; 71(4):199-202. PubMed ID: 31995958
[TBL] [Abstract][Full Text] [Related]
38. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
39. [Acquired hemophagocytic syndrome treated with HLH 94-04 chemotherapy protocol: Report of four cases].
Beffermann C N; Pilcante S J; Ocqueteau T M; Sarmiento M M
Rev Med Chil; 2015 Sep; 143(9):1172-8. PubMed ID: 26530200
[TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.
Nakanuma S; Gabata R; Okazaki M; Seki A; Hosokawa K; Yokoyama T; Katano K; Sugita H; Tokoro T; Takada S; Makino I; Taniguchi T; Harada K; Yagi S
Transplant Proc; 2023 Oct; 55(8):1946-1950. PubMed ID: 37537076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
